November 19, 2025
9:00 am – 4:00 pm
Register Here
Understanding Neuroplasticity and Recent Advancements in Enhancing Supports
The Office of Mental Health and Substance Abuse Services (OMHSAS) and the Office of Developmental Programs (ODP) invite you to register for the 2025 Dual Diagnosis Conference to be hosted virtually on November 19. Join us for this one-day virtual conference to gain a better understanding of neuroplasticity and recent advancements in enhancing supports for individuals with intellectual disabilities. There is no cost to attend, but registration is required.
Speakers for the day include:
Dr. Ken Martz
Ken Martz, PsyD, MBA, is a licensed psychologist, bestselling author, and expert in emotional development. He has worked in the treatment and management of addiction for the past 30 years across settings including outpatient, residential, and hospital settings. He was formerly the Special Assistant to the Secretary for the Department of Drug and Alcohol Programs in the Commonwealth of Pennsylvania and Policy Director in Substance Use Disorders of the Governor’s Policy Office. Dr. Martz will start the day with an overview of neuroplasticity.
Dr. Brandi Kelly
Brandi Kelly, PhD, is the Clinical Director for Louisiana’s OCDD. She received her doctoral degree in clinical psychology from Louisiana State University in 1998 and a post-doctoral master’s degree in clinical psychopharmacology from Alliant University in 2002. She has worked extensively in community- and residential-based programs providing support planning, staff training, and behavioral health services to individuals with developmental disabilities, and she has published research on assessment and treatment of behavioral and mental health concerns of individuals with developmental disabilities. Dr. Kelly’s presentation will provide a clinical focus on how to use neuroplasticity data.
Dr. Calliope Holingue
Calliope Holingue, MPH, PhD, is a research faculty member at the Center for Autism Services, Science, and Innovation at the Kennedy Krieger Institute. A psychiatric epidemiologist by training, she has a joint academic appointment as an assistant professor at the Department of Mental Health at Johns Hopkins. Dr. Holingue will share current research and developments related to neuroplasticity.
The day will conclude with a Q&A session with all three of our speakers.